Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease

被引:1067
作者
Ittner, Lars M. [1 ]
Goetz, Juergen [1 ]
机构
[1] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
A-BETA; PROTEIN-TAU; SYNAPTIC PLASTICITY; ANIMAL-MODELS; PRION PROTEIN; MOUSE MODEL; PHOSPHORYLATION; DEGENERATION; NEURODEGENERATION; LOCALIZATION;
D O I
10.1038/nrn2967
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amyloid-beta and tau are the two hallmark proteins in Alzheimer's disease. Although both amyloid-beta and tau have been extensively studied individually with regard to their separate modes of toxicity, more recently new light has been shed on their possible interactions and synergistic effects in Alzheimer's disease. Here, we review novel findings that have shifted our understanding of the role of tau in the pathogenesis of Alzheimer's disease towards being a crucial partner of amyloid-beta. As we gain a deeper understanding of the different cellular functions of tau, the focus shifts from the axon, where tau has a principal role as a microtubule-associated protein, to the dendrite, where it mediates amyloid-beta toxicity.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 65 条
  • [1] Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal
    Aronov, S
    Aranda, G
    Behar, L
    Ginzburg, I
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (17) : 6577 - 6587
  • [2] Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
    Ballatore, Carlo
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) : 663 - 672
  • [3] The genetic epidemidogy of neurodegenerative disease
    Bertram, L
    Tanzi, RE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) : 1449 - 1457
  • [4] Disease-related modifications in tau affect the interaction between Fyn and tau
    Bhaskar, K
    Yen, SH
    Lee, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35119 - 35125
  • [5] Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP x tau transgenic mice
    Bolmont, Tristan
    Clavaguera, Florence
    Meyer-Luehmann, Melanie
    Herzig, Martin C.
    Radde, Rebecca
    Staufenbiel, Matthias
    Lewis, Jada
    Hutton, Mike
    Tolnay, Markus
    Jucker, Mathias
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (06) : 2012 - 2020
  • [6] STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES
    BRAAK, H
    BRAAK, E
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (03) : 271 - 278
  • [7] DEVELOPMENTAL-CHANGES IN TAU-PHOSPHORYLATION - FETAL-TAU IS TRANSIENTLY PHOSPHORYLATED IN A MANNER SIMILAR TO PAIRED HELICAL FILAMENT-TAU CHARACTERISTIC OF ALZHEIMERS-DISEASE
    BRION, JP
    SMITH, C
    COUCK, AM
    GALLO, JM
    ANDERTON, BH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) : 2071 - 2080
  • [8] Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
    Brunden, Kurt R.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (10) : 783 - 793
  • [9] Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
    Cairns, Nigel J.
    Bigio, Eileen H.
    Mackenzie, Ian R. A.
    Neumann, Manuela
    Lee, Virginia M. -Y.
    Hatanpaa, Kimmo J.
    White, Charles L., III
    Schneider, Julie A.
    Grinberg, Lea Tenenholz
    Halliday, Glenda
    Duyckaerts, Charles
    Lowe, James S.
    Holm, Ida E.
    Tolnay, Markus
    Okamoto, Koichi
    Yokoo, Hideaki
    Murayama, Shigeo
    Woulfe, John
    Munoz, David G.
    Dickson, Dennis W.
    Ince, Paul G.
    Trojanowski, John Q.
    Mann, David M. A.
    [J]. ACTA NEUROPATHOLOGICA, 2007, 114 (01) : 5 - 22
  • [10] Strategies for disease modification in Alzheimer's disease
    Citron, M
    [J]. NATURE REVIEWS NEUROSCIENCE, 2004, 5 (09) : 677 - 685